The effect of rolipram, a type IV phosphodiesterase inhibitor, on Pseudomonas aeruginosa infection of respiratory mucosa

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 3, 1997, Pages 1565-1571

  Dowling, R B ^a   Johnson, M ^a,b   Cole, P J ^a   Wilson, R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GENTAMICIN; PENICILLIN G; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; SALMETEROL; STREPTOMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME IMMUNOASSAY; GRAM NEGATIVE INFECTION; HUMAN; HUMAN TISSUE; NOSE MUCOSA; ORGAN CULTURE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT MUCOSA; SCANNING ELECTRON MICROSCOPY;

BACTERIAL ADHESION; CALCIUM; CYCLIC AMP; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NASAL MUCOSA; ORGAN CULTURE TECHNIQUES; PHOSPHODIESTERASE INHIBITORS; PSEUDOMONAS AERUGINOSA; PYRROLIDINONES; ROLIPRAM;

EID: 0030961204     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. ANDERSON, G. P., LINDEN, A. AND RABE, K. F.: Why are long-acting beta-adrenoceptor agonists long acting? Eur. Respir. J. 7: 569-578, 1994.
2. AUERBACH, H. S., WILLIAMS, M., KIRKPATRICK, J. A. AND COLTEN, H. R.: Alternate day prednisolone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 2: 686-688, 1985.
3. BICKLER, P. E. AND HANSEN, B. M.: Causes of calcium accumulation in rat cortical brain slices during hypoxia and ischemia: Role of ion channels and membrane damage. Brain Res. 665: 269-276, 1994.
4. BOURNE, H. R., LICHTENSTEIN, L. M., MELMON, K. L., HENNEY, C. S., WEINSTEIN, Y. AND SHEARER, G. M.: Modulation of inflammation and immunity by cyclic AMP. Science (Wash. DC) 184: 19-28, 1974.
5. BRUNNEE, T., ENGELSTATTER, R., STEINIJANS, V. W. AND KUNKEL, G.: Bronchodilatory effects of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma. Eur. Respir. J. 5: 982-985, 1992.
6. DEVALIA, J. L., SAPSFORD, R. J., RUSZNAK, C., TOUMBIS, M. J. AND DAVIES, R. J.: The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells in vitro. Pulmon. Pharmacol. 5: 257-263, 1992.
7. DOWLING, R. B., RAYNER, C. F. J., RUTMAN, A., JACKSON, A. D., KANTHAKUMAR, K., DEWAR, A., TAYLOR, G. W., COLE, P. J., JOHNSON, M. AND WILSON, R.: Effect of salmeterol on Pseudomonas aeruginosa infection of respiratory mucosa. Am. J. Respir. Crit. Care Med. 155: 327-336, 1997.
8. FICK, R. B.: Pathogenesis of the Pseudomonas lung lesion in cystic fibrosis. Chest. 96: 158-164, 1989.
9. HODSON, M. E., PENKETH, A. R. L. AND BATTEN, J. C.: Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet 2: 1137-1139, 1981.
10. JACKSON, A. D., RAYNER, C. F. J., DEWAR, A., COLE, P. J. AND WILSON, R.: A human respiratory-tissue organ culture incorporating an air interface. Am. J. Respir. Crit. Care Med., 153: 1130-1135, 1996.
11. 2+ extrusion from human platlets. Biochim. Biophys. Acta. 1105: 19-28, 1992.
12. KANTHAKUMAR, K., TAYLOR, G., TSANG, K. W. T., CUNDELL, D. R., RUTMAN, A., SMITH, S., JEFFERY, P. K., COLE, P. J. AND WILSON, R.: Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect. Immun. 61: 2848-2853, 1993.
13. KANTHAKUMAR, K., CUNDELL, D. R., JOHNSON, M., WILLS, P. J., TAYLOR, G. W., COLE, P. J. AND WILSON, R.: Effect of salmeterol on human nasal epithelial cell ciliary beating: Inhibition of the ciliotoxin pyocyanin. Br. J. Pharmacol. 112: 493-498, 1994.
14. KHAIR, O. A., DEVALIA, J. L., ABDELAZIZ, M. M., SAPSFORD, R. J., TARAF, H., AND DAVIES, R. J.: Effect of Haemophilus influenzae endotoxin on the synthesis of IL,-6, IL-8, TNFα and expression of ICAM-1 in cultured human bronchial epithelial cells. Eur. Respir. J. 7: 2109-2116, 1994.
15. LEEMAN, M., LEJEUNE, P. AND NAEIJE, R.: Reduction in pulmonary hypertension and in airway resistances by enoximone (MDL 17,043) in decompensated COPD. Chest 91: 662-666, 1987.
16. LLEWELLYN-JONES, C. G., JOHNSON, M. M., MITCHELL, J. L., PYE, A., OKAFOR, V. C., HILL, S. AND STOCKELY, R. A.: In vivo study of indomethacin in bronchiectasis: Effect on neutrophil function and lung secretion. Eur. Resp. J. 8: 1479-1487, 1995.
17. MUNRO, N. C., BARKER, A., RUTMAN, A., TAYLOR, G., WATSON, D., MCDONALD-GIBSON, W. J., TOWART, R., TAYLOR, W. A. S., WILSON, R. AND COLE, P. J.: Effect of pyocyanin and 1-hydroxyphenazine on in vivo tracheal mucus velocity. J. Appl. Physiol. 67: 316-323, 1989.
18. MUSATA, M., MONDEN, M., UMESHITA, K., NAKANO, H., KANAI, T., GOTOH, M. AND MOTI, T.: Role of intracellular calcium in superoxide-induced hepatocyte injury. Hepatology 19: 1223-1228, 1994.
19. NASSERI-SINA, P., FAWTHROP, D. J., WILSON, J., BOOBIS, A. R. AND DAVIES, D. S.: Cytoprotection by iloprost against paracetamol-induced toxicity in hamster isolated hepatocytes. Br. J. Pharmacol. 105: 417-423, 1992.
20. 2-adrenoceptor agonist, salmeterol. Br. J. Pharmacol. 108: 507-515, 1993.
21. PIER, G. B.: Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: Current status of the host bacterium interaction. J. Infect. Dis. 151: 575-580, 1985.
22. PITT, T. L.: Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J. R. Soc. Med. 79: suppl. 13-18, 1986.
23. PLOTKOWSKI, M. C., CHEVIALARD, M., PIERROT, D., ALTEMAYER, D., ZAHM, J. M., COLLIOT, G. AND PUCHELLE, E.: Differential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture. J. Clin Invest. 87: 2018-2028, 1991.
24. RAMPHAL, R. AND PYLE, M.: Adherence of mucoid and non-mucoid Pseudomonas aeruginosa to acid-injured tracheal epithelium. Infect. Immun. 41: 345-351, 1983.
25. RAMPHAL, R., GUAY, C. AND PIER, G. B.: Pseudomonas aeruginosa adhesions for tracheobronchial mucin. Infect. Immun. 55: 600-603, 1987.
26. 2+ and cAMP messenger system in regulation of airway smooth muscle contraction. Am. J. Physiol. 258: L279-L288, 1990.
27. RAYNER, C. F. J., COLE, P. J. AND WILSON, R.: Management of chronic bronchial sepsis due to bronchiectasis. Clin. Pulm. Med. 1: 348-355, 1994a.
28. RAYNER, C. F. J., DEWAR, A., MOXON, E. R., VIRJI, M. AND WILSON, R.: The effect of variations in the expression of pili on the interaction of Neissera meningitdis with human nasopharyngeal epithelium. J. Infect. Dis. 171: 113-121, 1995.
29. RAYNER, C. F. J., TILLOTSON, G., COLE, P. J. AND WILSON, R.: Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. J. Antimicrob. Chemother. 34: 149-156, 1994b.
30. RIVA, C. M., MORGANROTH, L., LJUNGMAN, A. G., SCHOENEICH, S. O., MARKS, R. M., TODD, R. F., WARD, P. A. AND BOXER, L. A.: Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am. J. Respir. Cell Mol. Biol. 3: 301-309, 1990.
31. SCHAAD, U. B., LANG, A. B., WEDGEKOOD, A., RUEDEBERG, A., QUE, J. U., FURER, E. AND CRYZ JR., S. J.: Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. Lancet 338: 1236-1237, 1991.
32. SELDON, P. M., BARNES, P. J. AND GIEMBYCZ, M. A.: Phosphodiesterase IV inhibitors and β-adrenoceptor agonists suppress lipopolysaccharide-induced tumour necrosis factor α generation by human peripheral blood monocytes. Br. J. Pharmacol. 112: 215P, 1994.
33. SHAK, S., CAPON, D. J., HELLMISS, R., MARSTERS, S. A. AND BARKER, C. L.: Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc. Natl. Acad. Sci. U.S.A. 87: 9188-9192, 1990.
34. SUTTORP, U., WELSCH, N., WEBER, T. AND SCHUDT, C.: Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J. Clin. Invest. 91: 1421-1428, 1993.
35. TOMLINSON, P. R., WILSON, J. W. AND STEWART, A. G.: Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: Relationship to elevated cAMP levels. Biochem. Pharmacol. 48: 1809-1819, 1995.
36. TORPHY, T. J., ZHOU, H. L. AND CIESLINSKI, B.: Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J. Pharmacol. Exp. Ther. 263: 1195-1205, 1992.
37. TSANG, K. W. T., RUTMAN, A., TANAKA, E., LUND, V., DEWAR, A., COLE, P. J. AND WILSON, R.: Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur. Respir. J. 7: 1746-1753, 1994.
38. TURNER, C. R., ANDRESEN, C. J., SMITH, W. B. AND WATSON, J. W.: Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. Am. J. Resp. Crit. Care Med. 149: 1153-1159, 1994.
39. UNDERWOOD, D. C., KOTZER, C. J., BOCHNOWICZ, S., OSBORN, R. R., LUTTMANN, M. A., HAY, D. W. AND TORPHY, T. J.: Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J. Pharmacol. Exp. Ther. 270: 250-259, 1994.
40. WILSON, R., PITT, T., TAYLOR, G., WATSON, D., MACDERMOT, J., SYKES, D., ROBERTS, D. AND COLE, P. J.: Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J. Clin. Invest. 79: 221-229, 1987.
41. WILSON, R. & TSANG, K. W. T.: Antibiotics and the lung. In Drugs and the Lung, ed. by C. P. Page and W. J. Metzger, pp. 347-381, Raven Press, New York, 1994.